Even after anamnestic and clinical ascertainment that patients do not have any active infection or malignancy, as was the case in this study, CRP concentrations and SLE disease activity may still dissociate and challenge the biomarkers reliability in active SLE. The gene discussed is CRP; the disease is systemic lupus erythematosus.